From April 20 to 25, 2013, CFDA made a six-day inspection on 6 injectable lines of YaoPharma, including lyophilized powder for injection, powder for injection, large volume injection, small volume injection of Renhe site, as well as powder for injection (cephalosporins) of Nanan site, and eventually announced YaoPharma successfully passed the inspection.

YaoPharma has been implementing GMP for many years. Since the adoption of 2010 version of GMP, YaoPharma has always insisted throughout implementation of new GMP, strengthened the manufacturing practices and quality management, improved drug safety measures, introduced the concept of risk management and intensified GMP training to all staff. The approval of 6 injectable lines proved YaoPharma’s full compliance with new GMP, and laid a solid foundation for FDA site inspection late this year.